FDA Approves New Over-the-Counter Acetaminophen-Naproxen Combination

The FDA has approved the first over-the-counter fixed-dose combination of acetaminophen 650 mg and naproxen sodium 220 mg (Tylenol with naproxen, Kenvue). This new formulation aims to provide 12 hours of pain relief with a rapid onset of action. The approval includes a three-year period of exclusivity for this new OTC product, offering consumers a new option for pain management.